Best and brightest leukemia researchers receive $1-million from Cole Foundation

    Fellowships awarded to the Université de Montréal, McGill University and
    the Institut Armand-Frappier

    MONTREAL, June 2 /CNW Telbec/ - For the second year in a row, the Cole
Foundation is awarding $1-million in fellowships to the most promising
researchers studying pediatric leukemia and related diseases. The fellowships
will enable these young scientists from the Université de Montréal, McGill
University and the Institut Armand-Frappier to pursue their research.
    "With two major faculties of medicine and some of the best biomedical
research centres in the country, Montreal is home to an amazing concentration
of research talent," explains Barry Cole, President of the Cole Foundation.
"We're proud to support the next generation of leukemia researchers to help
maintain Montreal's tradition of medical excellence. By backing the most
promising talents, we hope to encourage their development. These are the
people who will gradually uncover the causes of leukemia, find new ways of
treating it and eventually eradicate all forms of the disease."
    Leukemia research has advanced considerably in recent years. Thirty years
ago, four out of five children suffering from acute forms of leukemia would
succumb to the disease. Today, research has reversed that situation: four out
of five children survive but there is greater concern for secondary illnesses
that develop later in life.
    "We have made very heartening progress in pediatric leukemia research
over the last few years, and we look forward to building on this success and
erasing the illness once and for all," notes Dr. Richard I. Levin,
Vice-Principal (Health Affairs) and Dean of the Faculty of Medicine at McGill
University. "The Cole Foundation provides truly outstanding support to our
cause by funding the research that is taking place in Montreal today and
encouraging the development of the researchers who will take this fight into
the future."
    "Our universities contribute significantly to healthcare research," said
Dr. Pierre Boyle, Vice-Dean of Research and Graduate Studies of the Faculty of
Medicine at the Université de Montréal. "They train most of the doctors and
researchers in the country, and they are the most active in terms of research.
The fellowship program established by the Cole Foundation helps us attract the
best researchers to form the elite teams we need to achieve convincing
results. All of these efforts come together to give patients the benefit of
the best treatment and, above all, to give them hope."
    Finally, Dr. Yves St-Pierre, professor at the INRS-Institut
Armand-Frappier congratulated the new Cole fellows: "They all have been
selected for the exceptional quality of their work. These young researchers
represent what science is at its best: dedication, passion and a constant
thirst for new knowledge. We are very proud to support them in the pursuit of
their work."
    The Cole Foundation research fellowship program offers $1-million over
two years to be divided among 21 clinical researchers, post-doctoral
researchers and students in doctoral and master's programs. Of the
21 recipients, 15 are associated with various research laboratories at the
Université de Montréal, including the Institute for Research in Immunology and
Cancer (IRIC), the Sainte-Justine Research Centre, and the Hôpital
Maisonneuve-Rosemont. Five fellowships will be distributed to students and
researchers working at McGill University and its associated hospitals and
research units, including the Royal Victoria Hospital and the Lady Davis
Research Centre at the Jewish General Hospital. One fellowship is awarded to a
student at the INRS-Institut Armand-Frappier.

    The Cole Foundation was created in 1980 by Montreal businessman John N.
(Jack) Cole to support Montreal hospitals and research in pediatric oncology
and hematology. After his only child, Penny, died of leukemia, he established
the Penny Cole Laboratory at the Montreal Children's Hospital. The purpose of
the lab was to foster research into the causes and potential cures for
leukemia and other related diseases affecting children. In 1997, the Cole
Foundation also endowed the Jack Cole Chair of Pediatric Oncology and
Hematology at McGill University.

    On the web:

For further information:

For further information: Pascal Zamprelli, Communications Officer,
McGill University, (514) 398-1385,; Julie Gazaille,
Press Attaché, Université de Montréal, (514) 343-6796,; John Moran, Secretary-Treasurer, Cole
Foundation, (819) 563-1716,; Source: Barry Cole, Cole

Organization Profile

Université de Montréal

More on this organization


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890